X
22Jan

Healthcare Antitrust – What to Expect in 2021

The year 2020 was an eventful one in the world of healthcare antitrust. The year began with the announcement of the precedent-setting settlement of the California Attorney General’s action against Sutter Health and ended with the settlement of multi-district antitrust litigation against the Blue Cross Blue Shield Association (and its member Blues)....
By: Akerman LLP - Health Law Rx
Source Url: https://www.jdsupra.com/legalnews/healthcare-antitrust-what-to-expect-in-1111203/

Related

Have You Gone Far Enough With a Coronavirus Crisis Management Plan?

It appears that we are in “hurry up and wait” mode. We know that COVID-19 (i.e., the 2019 Novel Co...

Read More >

State of the Cannabis Industry Conference: Capital Markets, Investments, M&A, Regulatory and Other Timely Issues

In both the Commonwealth and New England — and, indeed, the country — these are exciting times for...

Read More >

Preserving Privilege Post-Merger

The Delaware Court of Chancery recently upheld a provision in a merger agreement that prevented the ...

Read More >

The Blue Pencil Doctrine is Always an Eraser

Under Indiana law, courts have routinely employed the "blue pencil doctrine" to revise noncompetitio...

Read More >

Amended Court Rule Provides Certainty for CEQA Statutes of Limitations

On April 6, 2020, the Judicial Council of California (Council) adopted a court rule that tolled stat...

Read More >

OLNS#7 – Flip it Right: Two-Tier U.S. Holding Structures for German Start-ups

Mit unseren auf Technologietransaktionen spezialisierten Teams in allen wichtigen globalen Märkten b...

Read More >